Invacare SG&A Expenses 2010-2023 | IVCRQ
Invacare sg&a expenses from 2010 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Invacare Annual SG&A Expenses
(Millions of US $) |
| 2022 |
$227 |
| 2021 |
$232 |
| 2020 |
$236 |
| 2019 |
$260 |
| 2018 |
$282 |
| 2017 |
$297 |
| 2016 |
$304 |
| 2015 |
$319 |
| 2014 |
$382 |
| 2013 |
$397 |
| 2012 |
$407 |
| 2011 |
$393 |
| 2010 |
$385 |
| 2009 |
$399 |
Invacare Quarterly SG&A Expenses
(Millions of US $) |
| 2023-03-31 |
$54 |
| 2022-12-31 |
$52 |
| 2022-09-30 |
$55 |
| 2022-06-30 |
$59 |
| 2022-03-31 |
$61 |
| 2021-12-31 |
$54 |
| 2021-09-30 |
$56 |
| 2021-06-30 |
$64 |
| 2021-03-31 |
$59 |
| 2020-12-31 |
$62 |
| 2020-09-30 |
$56 |
| 2020-06-30 |
$57 |
| 2020-03-31 |
$62 |
| 2019-12-31 |
$63 |
| 2019-09-30 |
$64 |
| 2019-06-30 |
$68 |
| 2019-03-31 |
$65 |
| 2018-12-31 |
$67 |
| 2018-09-30 |
$70 |
| 2018-06-30 |
$74 |
| 2018-03-31 |
$71 |
| 2017-12-31 |
$73 |
| 2017-09-30 |
$76 |
| 2017-06-30 |
$76 |
| 2017-03-31 |
$73 |
| 2016-12-31 |
$75 |
| 2016-09-30 |
$78 |
| 2016-06-30 |
$79 |
| 2016-03-31 |
$73 |
| 2015-12-31 |
$78 |
| 2015-09-30 |
$77 |
| 2015-06-30 |
$82 |
| 2015-03-31 |
$81 |
| 2014-12-31 |
$87 |
| 2014-09-30 |
$98 |
| 2014-06-30 |
$100 |
| 2014-03-31 |
$97 |
| 2013-12-31 |
$92 |
| 2013-09-30 |
$98 |
| 2013-06-30 |
$104 |
| 2013-03-31 |
$103 |
| 2012-12-31 |
$98 |
| 2012-09-30 |
$103 |
| 2012-06-30 |
$104 |
| 2012-03-31 |
$101 |
| 2011-12-31 |
$71 |
| 2011-09-30 |
$104 |
| 2011-06-30 |
$112 |
| 2011-03-31 |
$106 |
| 2010-12-31 |
$77 |
| 2010-09-30 |
$102 |
| 2010-06-30 |
$104 |
| 2010-03-31 |
$102 |
| 2009-12-31 |
$102 |
| 2009-09-30 |
$104 |
| 2009-06-30 |
$98 |
| 2009-03-31 |
$94 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.000B |
$0.742B |
|
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
|
